$1.28 Billion in Sales Expected for Xylem Inc (XYL) This Quarter
Wall Street analysts expect that Xylem Inc (NYSE:XYL) will post sales of $1.28 billion for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Xylem’s earnings, with the highest sales estimate coming in at $1.29 billion and the lowest estimate coming in at $1.26 billion. Xylem posted sales of $1.10 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 16.4%. The firm is expected to report its next earnings report on Thursday, February 1st.
On average, analysts expect that Xylem will report full year sales of $1.28 billion for the current year, with estimates ranging from $4.69 billion to $4.72 billion. For the next fiscal year, analysts forecast that the company will report sales of $5.01 billion per share, with estimates ranging from $4.88 billion to $5.21 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Xylem.
Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.64 by $0.01. Xylem had a net margin of 6.85% and a return on equity of 17.74%. The company had revenue of $1.20 billion during the quarter, compared to analysts’ expectations of $1.18 billion. During the same quarter in the prior year, the company earned $0.54 EPS. The firm’s revenue was up 33.2% on a year-over-year basis.
Shares of Xylem (NYSE XYL) traded up $0.25 during trading on Monday, hitting $69.48. 554,692 shares of the stock were exchanged, compared to its average volume of 734,978. Xylem has a 12 month low of $46.67 and a 12 month high of $69.88. The stock has a market cap of $12,450.00, a PE ratio of 40.40, a price-to-earnings-growth ratio of 1.65 and a beta of 1.18. The company has a quick ratio of 1.26, a current ratio of 1.76 and a debt-to-equity ratio of 0.88.
In other Xylem news, insider Colin R. Sabol sold 38,070 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total value of $2,505,386.70. Following the completion of the transaction, the insider now directly owns 61,979 shares in the company, valued at approximately $4,078,837.99. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Steven R. Loranger sold 37,700 shares of the company’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $66.25, for a total transaction of $2,497,625.00. Following the completion of the transaction, the director now owns 58,831 shares of the company’s stock, valued at $3,897,553.75. The disclosure for this sale can be found here. Insiders sold a total of 150,777 shares of company stock valued at $10,097,757 over the last 90 days. Company insiders own 0.75% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the business. Chevy Chase Trust Holdings Inc. increased its stake in shares of Xylem by 0.9% in the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 197,184 shares of the industrial products company’s stock worth $12,349,000 after acquiring an additional 1,670 shares in the last quarter. Clinton Group Inc. bought a new position in shares of Xylem in the 2nd quarter worth about $3,292,000. Ameriprise Financial Inc. increased its stake in shares of Xylem by 17.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,727,985 shares of the industrial products company’s stock worth $151,210,000 after acquiring an additional 396,854 shares in the last quarter. Schroder Investment Management Group increased its stake in shares of Xylem by 17.0% in the 2nd quarter. Schroder Investment Management Group now owns 155,573 shares of the industrial products company’s stock worth $8,541,000 after acquiring an additional 22,568 shares in the last quarter. Finally, Highbridge Capital Management LLC bought a new position in shares of Xylem in the 3rd quarter worth about $254,000. Institutional investors and hedge funds own 85.04% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/01/08/1-28-billion-in-sales-expected-for-xylem-inc-xyl-this-quarter.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.